犹他大学获得了这两组基因的专利权,并把专利权转让给麦利亚德公司。
The University of Utah has patented the genes and licenses them to Myriad.
此外,麦利亚德公司将会向更高法院上述,这个案子很可能会被呈到最高法院。
What is more, Myriad will appeal to the higher courts, and the case may even end up at the Supreme court.
这些基因的变异增加了罹患乳腺癌的风险,麦利亚德通过这一专利出售基因检测服务。
Some versions of these genes increase the risk of breast cancer, and Myriad sells a test that detects these versions.
应用推荐